JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT CO., LTD. JiangSu WuZhong Pharmaceutical Development Co., Ltd. Stock
Equities
600200
CNE000000YP4
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.81 CNY | +0.56% |
|
+4.24% | +31.51% |
| Sales 2023 * | 2.27B 313M | Sales 2024 * | 2.83B 391M | Capitalization | 7.62B 1.05B |
|---|---|---|---|---|---|
| Net income 2023 * | 14M 1.93M | Net income 2024 * | 140M 19.32M | EV / Sales 2023 * | 3.36 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.69 x |
| P/E ratio 2023 * |
491
x | P/E ratio 2024 * |
55.2
x | Employees | 1,009 |
| Yield 2023 * |
-
| Yield 2024 * |
0.46% | Free-Float | 78.98% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.56% | ||
| 1 week | +4.24% | ||
| Current month | -7.37% | ||
| 1 month | +2.56% | ||
| 3 months | +20.51% | ||
| 6 months | +35.12% | ||
| Current year | +31.51% |
1 week
10.48
11.44
1 month
10.0013.88
Current year
6.9013.88
1 year
6.9013.88
3 years
5.4313.88
5 years
4.2713.88
10 years
4.2742.47
| Managers | Title | Age | Since |
|---|---|---|---|
Qun Shan Qian
CEO | Chief Executive Officer | 51 | 21-03-30 |
Zhen Bang Wu
CHM | Chairman | 59 | 99-12-31 |
Xi Sun
DFI | Director of Finance/CFO | 43 | 19-04-17 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tian Jiang Sun
BRD | Director/Board Member | 53 | 14-04-07 |
Tie Jun Gu
BRD | Director/Board Member | 43 | 20-11-08 |
Qun Ying Qian
BRD | Director/Board Member | 56 | 19-10-24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 10.81 | +0.56% | 35 797 420 |
| 24-04-23 | 10.75 | -3.15% | 34,122,510 |
| 24-04-22 | 11.1 | +1.46% | 44,820,040 |
| 24-04-19 | 10.94 | -1.53% | 39,501,080 |
| 24-04-18 | 11.11 | +4.03% | 59,800,860 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotes
JiangSu WuZhong Pharmaceutical Development Co Ltd, formerly Jiangsu Wuzhong Industrial Co Ltd, is a China-based company mainly engaged in pharmaceutical business. The Company's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.
Sector
Pharmaceuticals
Calendar
2024-04-24
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
10.81
CNY
Average target price
9.8
CNY
Spread / Average Target
-9.34%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +31.51% | 1.05B | |
| +25.45% | 672B | |
| +25.87% | 570B | |
| -5.58% | 360B | |
| +16.03% | 321B | |
| +8.55% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.93% | 149B |
- Stock Market
- Equities
- 600200 Stock
